Php34 - Time Analysis of the Drug Approval Process in Europe

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.930
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Ac1 - Outcome of New Drug Negotiation Process in Italy: Approval Conditions (2015-2018)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Debating Drug Approval Decisions

Cancer Discovery
Oncology
2013English

Law, Culture and Reprisals: A Qualitative Case Study of Whistleblowing & Health Canada's Drug Approval Process

English

First Tissue-Agnostic Drug Approval Issued

Cancer Discovery
Oncology
2017English

Pathways of Implementation of Multi-Criteria Decision Analysis Into Orphan Drug Approval Procedure for Drug Supply Programs in Russian Federation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

From the FDA: Panel Recommends Approval of Drug for ALS

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1995English

New Drug Approval Probability Model in Phased Clinical Trials

American Journal of Health Research
2013English

Analysis of Time to Regulatory and Ethical Approval of SATVI TB Vaccine Trials in South Africa

South African Medical Journal
Medicine
2012English

From the FDA: New Class of Asthma Drug Receives Advisory Approval

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy